PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
State of the Science in CKD: New Treatment, New Outcomes
Visit https://www.peervoice.com/BRJ860 to view the entire programme with slides. After completing “State of the Science in CKD: New Treatment, New Outcomes”, participants will be able to: Explain the rationale for SGLT2 inhibition in patients with chronic kidney disease (CKD), with or without type 2 diabetes (T2DM); Summarise the goals of therapy for patients with CKD, based on latest data; Apply updated strategies to the management of CKD, with the goal of improving outcomes and fostering a multidisciplinary approach